the impact of secondary aml mutations on the prognosis of patients with npm1-mutated aml
Published 1 year ago • 180 plays • Length 3:18Download video MP4
Download video MP3
Similar videos
-
1:45
the impact of secondary-type mutations in npm1-mutated aml
-
2:19
secondary-type mutations do not impact the favorable prognosis in npm1-mutated aml
-
2:59
the prognostic and therapeutic implications of mrd in aml
-
1:41
the emerging role of menin inhibitors in the treatment of npm1-mutated and kmt2a-rearranged r/r aml
-
4:51
the impact of idh mutated clones in npm1 aml
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
4:34
the genetics of acute myeloid leukemia (aml)
-
1:45
new research areas in the treatment of aml
-
2:26
impact of allelic state on os in tp53-mutant aml and hr-mds
-
4:43
treatment of npm1-mutated aml: intensive standard treatment
-
3:23
the prognostic value of idh1 and idh2 in acute myeloid leukemia (aml)
-
1:24
phase i study of cd123 nk cell engager sar443579 in r/r aml, b-all or hr-mds
-
2:34
the evolution of the aml treatment paradigm
-
45:46
acute myelogenous leukemia (aml)
-
5:15
impact of mmrd and eln genetic classification in outcomes for patients with aml underoging allohct
-
3:55
ziftomenib: a menin inhibitor for r/r npm1-mutated aml
-
1:42
developments in prognostic factors of acute myeloid leukemia (aml)
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
1:40
outcomes of allohsct in tp53-mutated aml and mds
-
1:02
the impact of sequencing in aml
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
1:34
secondary aml outcomes